- Published at
- by investing.com
neutral
neutral
GeneDx CEO Katherine Stueland sells shares worth over $66k By Investing.com
GeneDx CEO Katherine Stueland sells shares worth over $66k
News for CM Life Sciences, Inc. (CMLFW)
- Published at
- by seekingalpha.com
negativenegativeGeneDx Holdings: Mapping A Path To Leadership In Pediatric Genetic Testing (NASDAQ:WGS)
GeneDx Holdings is experiencing strong revenue growth and aims to achieve profitability by 2025. Find out if WGS stock is a buy.- Published at
- by investing.com
mixedmixedEarnings call: GeneDx posts revenue rise, eyes profitability by 2025 By Investing.com
Earnings call: GeneDx posts revenue rise, eyes profitability by 2025- Published at
- by marketscreener.com
mixedmixedMadryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company’s Proposed Merger with Standard BioTools
Files Preliminary Proxy Statement to Solicit Shareholders to Oppose the Merger Intends to Vote AGAINST the Conflict-Plagued and Excessively Dilutive Transaction, Which Stands to Unduly Benefit...- Published at
- by globenewswire.com
mixedmixedSomaLogic, Inc. (SLGC) Stock Investigation: Robbins LLP Reminds Investors it is Investigating SomaLogic, Inc.
SAN DIEGO, April 26, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating SomaLogic, Inc. (NASDAQ: SLGC) to determine...- Published at
- by globenewswire.com
mixedmixedBath & Body Works Board of Directors Sends Letter to Shareholders Highlighting Transformative Value-Creating Actions and Responding to Third Point’s Potential Proxy Contest
Bath & Body Works Has Undertaken Significant Changes to Become a Leading Standalone Personal Care and Home Fragrance Brand The Refreshed Bath &...- Published at
- by globenewswire.com
neutralneutralEQRx Reports Fourth Quarter and Full Year 2022 Financial
For Investors Lerociclib: Ongoing Phase 2 trial in first- and second-line treatment of metastatic breast cancer; expect to initiate Phase 3 trial in...- Published at
- by insidermonkey.com
mixedmixed- Published at
- by globenewswire.com
mixedmixed(SPAC) Special Purpose Acquisition Investigation: SMFR, SFT, SKIL, SMRT, Contact Shareholder Rights Law Firm Johnson Fistel
SAN DIEGO, Jan. 14, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection...- Published at
- by globenewswire.com
positivepositiveSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sema4 Holdings Corp. – SMFR; SMFRW
NEW YORK, Oct. 30, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sema4 Holdings Corp. (“Sema4” or the...- Published at
- by etfdailynews.com
mixedmixed- Published at
- by etfdailynews.com
mixedmixed- Published at
- by globenewswire.com
mixedmixedEQRx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Progress
First regulatory submissions for lead oncology programs aumolertinib and sugemalimab are expected to be ex-U.S. in 2H 2022; continuing to engage in...